Payments by organ transplant recipients and Medicare decreased significantly following the introduction of generic immunosuppressive medications.

Large differences in out-of-pocket payments for immunosuppressive medications between Part D beneficiaries who did and did not qualify for the Medicare low-income subsidy suggest that recipients with resources just above the threshold to qualify for the subsidy may experience considerable financial strain.